|
HY-140696E-1g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-140696E-5g
|
MedChemexpress LLC
|
m-PEG-OH (MW 1000) [CAS 9004-74-4]
|
|
|
|
|
HY-139915-10mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-100mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-25mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-5mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-139915-50mg
|
MedChemexpress LLC
|
MPO-IN-1 [CAS 2471981-21-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-110347-10mg
|
MedChemexpress LLC
|
Mps1-IN-1 (dihydrochloride) [CAS 1883548-93-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-110347-5mg
|
MedChemexpress LLC
|
Mps1-IN-1 (dihydrochloride) [CAS 1883548-93-3]
|
|
Cancer-Kinase/protease
|
|
|
HY-145426-10mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-100mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-25mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-5mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-50mg
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8]
|
|
Cancer-programmed cell death
|
|
|
HY-145426-1mL
|
MedChemexpress LLC
|
MPT0B390 [CAS 1817802-18-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-124295-10mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-100mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-25mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-5mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-124295-50mg
|
MedChemexpress LLC
|
MPT0E028 [CAS 1338320-94-7]
|
|
Cancer-Kinase/protease
|
|
|
HY-145997-1mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-147051-100mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-2 [CAS 2492595-24-9]
|
|
COVID-19-immunoregulation
|
|
